Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi(Broad Institute), Franklin W. Huang(Dana-Farber Cancer Institute), Judit Jané‐Valbuena(Broad Institute), Gregory V. Kryukov(Broad Institute), Christopher Lo(Broad Institute), E. Robert McDonald(Novartis (United States)), Jordi Barretina(Novartis (United States)), Ellen Gelfand(Broad Institute), Craig M. Bielski(Broad Institute), Haoxin Li(Broad Institute), Kevin Hu(Broad Institute), Alexander Andreev-Drakhlin(Broad Institute), Jaegil Kim(Broad Institute), Julian M. Hess(Broad Institute), Brian J. Haas(Broad Institute), François Aguet(Broad Institute), Barbara A. Weir(Broad Institute), Michael Rothberg(Broad Institute), Brenton R. Paolella(Broad Institute), Michael S. Lawrence(Harvard University), Rehan Akbani(The University of Texas MD Anderson Cancer Center), Yiling Lu(The University of Texas MD Anderson Cancer Center), Hong L. Tiv, Prafulla C. Gokhale, Antoine de Weck(Novartis Institutes for BioMedical Research), Ali Amin Mansour(Broad Institute), Coyin Oh(Broad Institute), Juliann Shih(Broad Institute), Kevin Hadi(Weill Cornell Medicine), Yanay Rosen(Broad Institute), Jonathan Bistline(Broad Institute), K. Venkatesan(Novartis (United States)), Anupama Reddy(Novartis (United States)), Dmitriy Sonkin(National Cancer Institute), Manway Liu(Novartis (United States)), Joseph Lehár(Novartis (United States)), Joshua M. Korn(Novartis (United States)), Dale Porter(Novartis (United States)), Michael D. Jones(Novartis (United States)), Javad Golji(Novartis (United States)), Giordano Caponigro(Novartis (United States)), Jordan E. Taylor(Broad Institute), Caitlin M. Dunning(Broad Institute), Amanda L. Creech(Broad Institute), Allison Warren(Broad Institute), James M. McFarland(Broad Institute), Mahdi Zamanighomi(Broad Institute), Audrey Kauffmann(Novartis Institutes for BioMedical Research), Nicolas Stransky(Broad Institute), Marcin Imieliński(Weill Cornell Medicine), Yosef E. Maruvka(Broad Institute), Andrew D. Cherniack(Dana-Farber Cancer Institute), Aviad Tsherniak(Broad Institute), Francisca Vázquez(Broad Institute), Jacob D. Jaffe(Broad Institute), Andrew A. Lane(Dana-Farber Cancer Institute), David M. Weinstock(Dana-Farber Cancer Institute), Cory M. Johannessen(Broad Institute), Michael Morrissey(Novartis (United States)), Frank Stegmeier(Novartis (United States)), Robert Schlegel(Novartis (United States)), William C. Hahn(Broad Institute), Gad Getz(Broad Institute), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Jesse S. Boehm(Broad Institute), Todd R. Golub(Dana-Farber Cancer Institute), Levi A. Garraway(Dana-Farber Cancer Institute), William R. Sellers(Novartis (United States))
Cited by 3,677Open Access
Abstract
Related Papers
From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline
Géraldine Van der Auwera, Mauricio O. Carneiro, Christopher Hartl et al.|Current Protocols in Bioinformatics|2013|7.2k